Search company, investor...

Salutaris Medical Devices

salutarismd.com

Stage

Series D | Alive

Total Raised

$10.82M

About Salutaris Medical Devices

Salutaris Medical Devices (SalutarisMD) is a clinical-stage medical device company developing an investigational ophthalmic treatment for Wet Age-related Macular Degeneration (Wet AMD). SalutarisMD is developing a minimally invasive procedure that can be performed in an outpatient or physician office setting in approximately 15 minutes.

Headquarters Location

4330 N Campbell Ave #250

Tucson, Arizona, 85718,

United States

520-299-3510

Missing: Salutaris Medical Devices's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Salutaris Medical Devices's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Salutaris Medical Devices

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Salutaris Medical Devices is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

11,648 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health IT

7,901 items

Salutaris Medical Devices Patents

Salutaris Medical Devices has filed 1 patent.

The 3 most popular patent topics include:

  • Diseases of the eye and adnexa
  • Disorders of sclera and cornea
  • Dosage forms
patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/15/2018

12/1/2020

Radiation therapy, Diseases of the eye and adnexa, Disorders of sclera and cornea, Medical physics, Ophthalmology

Grant

Application Date

1/15/2018

Grant Date

12/1/2020

Title

Related Topics

Radiation therapy, Diseases of the eye and adnexa, Disorders of sclera and cornea, Medical physics, Ophthalmology

Status

Grant

Latest Salutaris Medical Devices News

Salutaris Medical Devices Receives 510(k) Clearance from U.S. FDA for SMD-Sr90-DA Radionuclide Brachytherapy Source

Dec 20, 2016

Thumbnail December 20, 2016 12:02 AM Eastern Standard Time TUCSON, Ariz.--( BUSINESS WIRE )--Salutaris Medical Devices, Inc. (SalutarisMD®) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for their SMD-Sr90-DA™ Radionuclide Brachytherapy Source (RBS). The SMD-Sr90-DA™ RBS device is indicated for episcleral brachytherapy. The device is intended for use within a manual brachytherapy applicator system. Dr. Laurence Marsteller, CEO of SalutarisMD, commented, "The SalutarisMD team is quite proud and excited to have reached this important regulatory and commercial milestone. It further validates our company's progress, and advances its clinical research agenda. " SalutarisMD is developing a minimally invasive procedure that can be performed in an outpatient setting in approximately 15 minutes. The patented and patent pending technology delivers a single-use brachytherapy procedure. SalutarisMD's technology is being engineered to deliver improved outcomes for wet AMD. Caution: Investigational Device About SalutarisMD SalutarisMD® (Salutaris Medical Devices, Inc. and Salutaris Medical Devices, Ltd.) is a pre-revenue medical device company founded to develop an investigational ophthalmic treatment for wet age-related macular degeneration (wet AMD). HOYA Group announced in March 2015 that it had closed an investment financing in SalutarisMD to further SalutarisMD's growth strategy. For more information visit www.SalutarisMD.com or www.SalutarisMD.co.uk . Salutaris Medical Devices, Inc. 4340 N. Campbell Ave. Suite 266 Tucson, AZ 85718

Salutaris Medical Devices Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Salutaris Medical Devices Rank

Salutaris Medical Devices Frequently Asked Questions (FAQ)

  • Where is Salutaris Medical Devices's headquarters?

    Salutaris Medical Devices's headquarters is located at 4330 N Campbell Ave, Tucson.

  • What is Salutaris Medical Devices's latest funding round?

    Salutaris Medical Devices's latest funding round is Series D.

  • How much did Salutaris Medical Devices raise?

    Salutaris Medical Devices raised a total of $10.82M.

  • Who are the investors of Salutaris Medical Devices?

    Investors of Salutaris Medical Devices include Desert Angels, Translational Accelerator and Tucson Desert Angels.

  • Who are Salutaris Medical Devices's competitors?

    Competitors of Salutaris Medical Devices include Wright Medical Group, Relievant Medsystems, SteadyMed Therapeutics, DFine, Spinal Modulation and 13 more.

Compare Salutaris Medical Devices to Competitors

BioWave Logo
BioWave

BioWave is a neuromodulation pain therapy company whose major goal is to help physicians, physical therapists and athletic trainers manage their patients' or athletes pain and reduce or eliminate the use of opiates, NSAIDs and their associated side effects. Biowave devices deliver a therapeutic electrical signal into deep tissue in the body blocking the transmission of pain.

F
Facet Solutions

Facet Solutions has developed a total replacement for the facet joint to treat back pain from hypertrophy.

A
AllTranz

AllTranz aims to provide relief from chronic pain to patients outside the hospital setting.

T
Trigemina

Trigemina is focused on the discovery and development of non-narcotic, nasally delivered, analgesic drug products. Trigemina's lead product candidate, TI-001, is a patented new application of oxytocin. TI-001 has shown promising results for use as a safe and effective therapy for all forms of chronic and subacute head pain.

M
MetaCure

MetaCure is a clinical-stage device company focused on the treatment of adult type II diabetes via an implantable pulse generator delivering electrical stimulation via gastric contractility modulation.

C
Cerene Biomedics

Cerene Biomedics is developing an implantable medical device that will prevent epileptic seizures

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.